MedTrace Logo

Neuraxial Pethidine After Lumbar Surgery Trial

NCT00163553 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2009-01-30

No results posted yet for this study

Summary

The hypothesis is that epidural pethidine is an effective form of pain relief following lumbar spinal surgery, resulting in significantly lower usage of concomitantly administered (intravenous) patient-controlled analgesia (PCA) pethidine.

Conditions

  • Sciatica

Interventions

DRUG

Pethidine

DRUG

Placebo

Sponsors & Collaborators

  • Austin Health

    lead OTHER_GOV

Principal Investigators

  • Dean A Cowie, MBBS, FANZCA · Austin Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00163553 on ClinicalTrials.gov